Stability-indicating RP-HPLC method development and validation for duloxetine hydrochloride in tablets. 2010

Sejal K Patel, and Natavarlal J Patel, and Arun M Prajapati, and Dipti B Patel, and Satish A Patel
Ganpat University, S.K. Patel College of Pharmaceutical Education and Research, Department of Pharmaceutical Chemistry, Kherva-382711, Mehsana, Gujarat, India. skpatel_2@rediffmail.com

This paper describes the development of a stability-indicating RP-HPLC method for duloxetine hydrochloride (DLX) in the presence of its degradation products generated from forced decomposition studies. The drug substance was found to be susceptible to stress conditions of acid, base, oxidation, wet heat, dry heat, and photodegradation. The drug was found to be stable to the dry heat condition attempted. Successful separation of the drug from the degradation products formed under stress conditions was achieved on a Phenomenex C18 column (250 x 4.6 mm id, 5 microm particle size) using acetonitrile-methanol-0.032 M ammonium acetate buffer (55 + 05 + 40, v/v/v) as the mobile phase at a flow rate of 1.0 mL/min at 40 degrees C temperature. Quantification was achieved with photodiode array detection at 290 nm over the concentration range 0.2-5 microg/mL with mean recovery of 101.048 +/- 0.53% for DLX by the RP-HPLC method. Statistical analysis proved the method is repeatable, specific, and accurate for estimation of DLX. Because the method could effectively separate the drug from its degradation products, it can be used as a stability-indicating method.

UI MeSH Term Description Entries
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010782 Photolysis Chemical bond cleavage reactions resulting from absorption of radiant energy. Photodegradation
D012015 Reference Standards A basis of value established for the measure of quantity, weight, extent or quality, e.g. weight standards, standard solutions, methods, techniques, and procedures used in diagnosis and therapy. Standard Preparations,Standards, Reference,Preparations, Standard,Standardization,Standards,Preparation, Standard,Reference Standard,Standard Preparation,Standard, Reference
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006358 Hot Temperature Presence of warmth or heat or a temperature notably higher than an accustomed norm. Heat,Hot Temperatures,Temperature, Hot,Temperatures, Hot
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000068736 Duloxetine Hydrochloride A thiophene derivative and selective NEUROTRANSMITTER UPTAKE INHIBITOR for SEROTONIN and NORADRENALINE (SNRI). It is an ANTIDEPRESSIVE AGENT and ANXIOLYTIC, and is also used for the treatment of pain in patients with DIABETES MELLITUS and FIBROMYALGIA. Cymbalta,Duloxetine,Duloxetine Ethanedioate (1:1), (+-)-isomer - T353987,Duloxetine HCl,Duloxetine, (+)-isomer,LY 227942,LY 248686,LY-227942,LY-248686,LY227942,N-methyl-3-(1-naphthalenyloxy)-2-thiophenepropanamine,N-methyl-3-(1-naphthalenyloxy)-3-(2-thiophene)propanamide,HCl, Duloxetine,Hydrochloride, Duloxetine,LY248686
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant

Related Publications

Sejal K Patel, and Natavarlal J Patel, and Arun M Prajapati, and Dipti B Patel, and Satish A Patel
January 2010, Scientia pharmaceutica,
Sejal K Patel, and Natavarlal J Patel, and Arun M Prajapati, and Dipti B Patel, and Satish A Patel
May 2014, Indian journal of pharmaceutical sciences,
Sejal K Patel, and Natavarlal J Patel, and Arun M Prajapati, and Dipti B Patel, and Satish A Patel
April 2008, Chemical & pharmaceutical bulletin,
Sejal K Patel, and Natavarlal J Patel, and Arun M Prajapati, and Dipti B Patel, and Satish A Patel
September 2009, Indian journal of pharmaceutical sciences,
Sejal K Patel, and Natavarlal J Patel, and Arun M Prajapati, and Dipti B Patel, and Satish A Patel
August 2023, Turkish journal of pharmaceutical sciences,
Sejal K Patel, and Natavarlal J Patel, and Arun M Prajapati, and Dipti B Patel, and Satish A Patel
January 2012, Scientia pharmaceutica,
Sejal K Patel, and Natavarlal J Patel, and Arun M Prajapati, and Dipti B Patel, and Satish A Patel
January 2013, Analytical chemistry insights,
Sejal K Patel, and Natavarlal J Patel, and Arun M Prajapati, and Dipti B Patel, and Satish A Patel
January 2014, International scholarly research notices,
Sejal K Patel, and Natavarlal J Patel, and Arun M Prajapati, and Dipti B Patel, and Satish A Patel
November 2010, Indian journal of pharmaceutical sciences,
Sejal K Patel, and Natavarlal J Patel, and Arun M Prajapati, and Dipti B Patel, and Satish A Patel
September 2010, Indian journal of pharmaceutical sciences,
Copied contents to your clipboard!